Viatris completes $36.50-per-share acquisition of Pacira BioSciencesNov 17FinancingPacira Pharmaceuticals, Inc
Pacira withdraws 2026 guidance, skips earnings release amid Viatris tender offerNov 5M&APacira Pharmaceuticals, Inc
Viatris to acquire Pacira BioSciences for $36.50 per share in cashOct 8M&APacira Pharmaceuticals, IncViatris Inc.
Pacira reports Q2 2026 results, updates guidance after iovera° sale to Zimmer BiometAug 4Quarterly updateenekinragene inzadenovecPacira Pharmaceuticals, Inc
Pacira to divest iovera° cryoneurolysis business to Zimmer BiometJun 30M&APacira Pharmaceuticals, Inc